Patmore R - Search Results

1

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.

McMillan AK, Phillips EH, Kirkwood AA, Barrans S, Burton C, Rule S, Patmore R, Pettengell R, Ardeshna KM, Lawrie A, Montoto S, Paneesha S, Clifton-Hadley L, Linch DC. McMillan AK, et al. Among authors: patmore r. Ann Oncol. 2020 Sep;31(9):1251-1259. doi: 10.1016/j.annonc.2020.05.016. Epub 2020 May 26. Ann Oncol. 2020. PMID: 32464282 Free PMC article. Clinical Trial.

2

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma.

Barrans SL, Carter I, Owen RG, Davies FE, Patmore RD, Haynes AP, Morgan GJ, Jack AS. Barrans SL, et al. Blood. 2002 Feb 15;99(4):1136-43. doi: 10.1182/blood.v99.4.1136. Blood. 2002. PMID: 11830458 Free article.

3

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.

Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A; Haematological Malignancy Research Network. Smith A, et al. Among authors: patmore r. Br J Haematol. 2010 Mar;148(5):739-53. doi: 10.1111/j.1365-2141.2009.08010.x. Epub 2009 Dec 1. Br J Haematol. 2010. PMID: 19958356 Free PMC article.

4

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab.

Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R, Roman E, Jack A. Barrans S, et al. Among authors: patmore r. J Clin Oncol. 2010 Jul 10;28(20):3360-5. doi: 10.1200/JCO.2009.26.3947. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498406

5

Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome.

Barrans SL, Crouch S, Care MA, Worrillow L, Smith A, Patmore R, Westhead DR, Tooze R, Roman E, Jack AS. Barrans SL, et al. Among authors: patmore r. Br J Haematol. 2012 Nov;159(4):441-53. doi: 10.1111/bjh.12045. Epub 2012 Sep 13. Br J Haematol. 2012. PMID: 22970711 Free article.

6

Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.

Leblond V, Johnson S, Chevret S, Copplestone A, Rule S, Tournilhac O, Seymour JF, Patmore RD, Wright D, Morel P, Dilhuydy MS, Willoughby S, Dartigeas C, Malphettes M, Royer B, Ewings M, Pratt G, Lejeune J, Nguyen-Khac F, Choquet S, Owen RG. Leblond V, et al. J Clin Oncol. 2013 Jan 20;31(3):301-7. doi: 10.1200/JCO.2012.44.7920. Epub 2012 Dec 10. J Clin Oncol. 2013. PMID: 23233721 Clinical Trial.

7

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma.

Smith A, Crouch S, Howell D, Burton C, Patmore R, Roman E. Smith A, et al. Among authors: patmore r. Cancer Epidemiol. 2015 Dec;39(6):1103-12. doi: 10.1016/j.canep.2015.08.015. Epub 2015 Sep 2. Cancer Epidemiol. 2015. PMID: 26341588 Free PMC article.

8

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort.

Wang HI, Smith A, Aas E, Roman E, Crouch S, Burton C, Patmore R. Wang HI, et al. Among authors: patmore r. Eur J Health Econ. 2017 Mar;18(2):255-267. doi: 10.1007/s10198-016-0775-4. Epub 2016 Mar 11. Eur J Health Econ. 2017. PMID: 26969332 Free PMC article.

9

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network.

Kane E, Howell D, Smith A, Crouch S, Burton C, Roman E, Patmore R. Kane E, et al. Among authors: patmore r. Eur J Cancer. 2017 Jun;78:53-60. doi: 10.1016/j.ejca.2017.03.013. Epub 2017 Apr 13. Eur J Cancer. 2017. PMID: 28412589 Free PMC article.

10

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN).

Smith A, Roman E, Appleton S, Howell D, Johnson R, Burton C, Patmore R. Smith A, et al. Among authors: patmore r. Br J Haematol. 2018 Apr;181(2):215-228. doi: 10.1111/bjh.15170. Epub 2018 Mar 13. Br J Haematol. 2018. PMID: 29532919 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters